 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
15 July 1996 | Volume 125 Issue 2 | Pages 126-136
Cytomegalovirus (CMV) retinitis, a common complication of the acquired immunodeficiency syndrome (AIDS), is increasing in frequency as patients infected with the human immunodeficiency virus (HIV) live longer.In recent years, the lifetime risk for CMV disease in HIV-infected persons has increased from 24.9% to 44.9%. Cytomegalovirus retinitis is usually diagnosed clinically: Almost all patients are CMV seropositive and have CD4+ counts less than 50 cells/mm3. Specific diagnostic tests that use antigen detection or quantitation of circulating nucleic acid to detect CMV are being developed, but they have not been validated for routine clinical use. Such tests would help predict disease, diagnose acute retinitis, and monitor therapy.
Author and Article Information
Moderator: Masur, Henry MD; Discussants: Whitcup, Scott M. MD; Cartwright, Charles PhD; Polis, Michael MD; Nussenblatt, Robert MD
NIH CONFERENCE
Advances in the Management of AIDS-Related Cytomegalovirus Retinitis
An edited and updated summary of a conference held on 18 October 1995 at the Clinical Center of the National Institutes of Health, Bethesda, Maryland.
Authors who wish to cite a section of the conference and specifically indicate its author may use this example for the form of the reference:
Whitcup SM. Diagnosis, screening, and prognosis, pp 127-128. In: Masur H, moderator. Advances in the management of AIDS-related cytomegalovirus retinitis. Ann Intern Med. 1996; 125:126-136
Requests for Reprints: Henry Masur, MD, Critical Care Medicine Department, National Institutes of Health, Building 10, Room 7D43, Bethesda, MD 20892.
Current Author Addresses: Dr. Masur: Critical Care Medicine Department, National Institutes of Health, Building 10, Room 7D43, Bethesda, MD 20892.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  G. Chan, E. R. Bivins-Smith, M. S. Smith, P. M. Smith, and A. D. Yurochko Transcriptome Analysis Reveals Human Cytomegalovirus Reprograms Monocyte Differentiation toward an M1 Macrophage J. Immunol., July 1, 2008; 181(1): 698 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. L. Bentz, M. Jarquin-Pardo, G. Chan, M. S. Smith, C. Sinzger, and A. D. Yurochko Human Cytomegalovirus (HCMV) Infection of Endothelial Cells Promotes Naive Monocyte Extravasation and Transfer of Productive Virus To Enhance Hematogenous Dissemination of HCMV J. Virol., December 1, 2006; 80(23): 11539 - 11555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Smith, G. L. Bentz, P. M. Smith, E. R. Bivins, and A. D. Yurochko HCMV activates PI(3)K in monocytes and promotes monocyte motility and transendothelial migration in a PI(3)K-dependent manner J. Leukoc. Biol., July 1, 2004; 76(1): 65 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Smith, G. L. Bentz, J. S. Alexander, and A. D. Yurochko Human Cytomegalovirus Induces Monocyte Differentiation and Migration as a Strategy for Dissemination and Persistence J. Virol., May 1, 2004; 78(9): 4444 - 4453. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. VELEZ and S. M WHITCUP New developments in sustained release drug delivery for the treatment of intraocular disease Br. J. Ophthalmol., November 1, 1999; 83(11): 1225 - 1229. [Full Text]
|
|
|
|
 |
|
 S. L. Zeichner Foscarnet Pediatr. Rev., December 1, 1998; 19(12): 399 - 400. [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Whitley, M. A. Jacobson, D. N. Friedberg, G. N. Holland, D. A. Jabs, D. T. Dieterich, W. D. Hardy, M. A. Polis, T. A. Deutsch, J. Feinberg, et al. Guidelines for the Treatment of Cytomegalovirus Diseases in Patients With AIDS in the Era of Potent Antiretroviral Therapy: Recommendations of an International Panel Arch Intern Med, May 11, 1998; 158(9): 957 - 969. [Abstract] [Full Text] [PDF]
|
|
Article
